Description
This portfolio is designed to benefit from the strong earnings that companies in this space are enjoying. Although, some of the companies in this portfolio may be experiencing increased competition from generic drug makers the long term prospects for pharma and biotech companies that are included in the S&P and DOW indexes are extremely bright.
Reviews
There are no reviews yet.